Drugs / [18F]PARPi
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04173104 | Nov 2019 → Feb 2026 | brain cancer, primary brain neoplasm | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]PARPi | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04173104 ↗ |
| Modality | Diagnostic / imaging agent | “Diagnostic Test: PET/MR with [18F]PARPi” NCT04173104 ↗ |